Medicare Enrolled
Dr. Gajanan Kulkarni, MD
Medical Oncology · Trinity, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kulkarni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kulkarni? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kulkarni
Dr. Gajanan Kulkarni is a medical oncology in Trinity, FL, with 20 years in practice. Based on federal Medicare data, Dr. Kulkarni performed 49,306 Medicare services across 1,823 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kulkarni received a total of $18,351 from 86 pharmaceutical and/or device companies across 975 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kulkarni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 34% volume in FL$ $18,351 industry payments
Medicare Practice Summary
Medicare Utilization ↗49,306
Medicare services
Top 34% in FL for medical oncology
1,823
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,465 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 33,150 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia | 5,136 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 2,580 | $18 | $51 |
| Complete blood count (CBC) with differential | 1,666 | $8 | $29 |
| Blood draw (venipuncture) | 1,525 | $8 | $9 |
| Office visit, established patient (20-29 min) | 790 | $65 | $239 |
| Dexamethasone injection (steroid) | 782 | $0 | $3 |
| Anti-nausea injection (ondansetron/Zofran) | 592 | $0 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 580 | $1 | $28 |
| Drug injection, under skin or into muscle | 464 | $10 | $69 |
| Injection of additional new drug or substance into vein | 286 | $12 | $60 |
| Administration of chemotherapy into vein, 1 hour or less | 237 | $96 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 222 | $21 | $84 |
| Injection, diphenhydramine hcl, up to 50 mg | 167 | $1 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 162 | $1 | $6 |
| Office visit, established patient (30-39 min) | 139 | $98 | $339 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 118 | $17 | $59 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 109 | $3 | $11 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 104 | $48 | $189 |
| Administration of additional new drug or substance into vein, 1 hour or less | 67 | $49 | $178 |
| Infusion into a vein for hydration, each additional hour | 61 | $10 | $42 |
| Infusion into a vein for hydration, 31-60 minutes | 54 | $24 | $156 |
| Administration of chemotherapy into vein, each additional hour | 51 | $21 | $79 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 48 | $1 | $7 |
| Infusion, normal saline solution , 1000 cc | 45 | $2 | $7 |
| New patient office visit (45-59 min) | 41 | $125 | $453 |
| Red blood count, automated test | 34 | $4 | $10 |
| Injection of drug or substance into vein | 33 | $28 | $156 |
| Drawing of blood for a medical problem | 27 | $63 | $277 |
| Hospital follow-up visit, moderate complexity | 24 | $60 | $197 |
| Initial hospital admission, high complexity | 12 | $137 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
68.3% high complexity
22.7% medium
9.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,351
Total received (2018-2024)
Avg $2,622/year across 7 years
Top 27% in FL for medical oncology
86
Companies
975
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,483 (95.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$867 (4.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,879
2023$3,853
2022$2,925
2021$1,658
2020$1,434
2019$2,527
2018$2,074
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,281
E.R. Squibb & Sons, L.L.C.
$1,187
Lilly USA, LLC
$1,037
AstraZeneca Pharmaceuticals LP
$950
Janssen Biotech, Inc.
$929
Astellas Pharma US Inc
$915
Incyte Corporation
$681
PFIZER INC.
$674
Seagen Inc.
$673
Merck Sharp & Dohme Corporation
$638
Amgen Inc.
$589
Merck Sharp & Dohme LLC
$564
Celgene Corporation
$498
Genentech USA, Inc.
$491
Bayer HealthCare Pharmaceuticals Inc.
$447
GENZYME CORPORATION
$424
Bayer Healthcare Pharmaceuticals Inc.
$409
Daiichi Sankyo Inc.
$392
Gilead Sciences, Inc.
$360
ARRAY BIOPHARMA INC
$332
Takeda Pharmaceuticals U.S.A., Inc.
$302
Eisai Inc.
$259
Boehringer Ingelheim Pharmaceuticals, Inc.
$244
Regeneron Healthcare Solutions, Inc.
$238
GlaxoSmithKline, LLC.
$202
FUJIFILM Healthcare Americas Corporation
$188
EMD Serono, Inc.
$158
Mirati Therapeutics, Inc.
$157
PUMA BIOTECHNOLOGY, INC.
$146
ABBVIE INC.
$143
Kite Pharma, Inc.
$139
Alexion Pharmaceuticals, Inc.
$138
EISAI INC.
$121
Puma Biotechnology, Inc.
$110
Pharmacyclics LLC, An AbbVie Company
$109
Karyopharm Therapeutics Inc.
$108
Stemline Therapeutics Inc.
$107
Exelixis Inc.
$101
Blueprint Medicines Corporation
$91
JAZZ PHARMACEUTICALS INC.
$87
Janssen Pharmaceuticals, Inc
$82
Seattle Genetics, Inc.
$81
Rigel Pharmaceuticals, Inc.
$75
BeiGene USA, Inc.
$72
AMAG Pharmaceuticals, Inc.
$62
PharmaEssentia USA Corporation
$61
SOBI, INC
$57
MorphoSys, US Inc.
$57
Helsinn Therapeutics (U.S.), Inc.
$55
G1 Therapeutics, Inc.
$54
AbbVie, Inc.
$51
Octapharma USA, Inc.
$50
Pharmacyclics LLC, an AbbVie Company
$50
Genmab U.S., Inc.
$48
MEDIVATION FIELD SOLUTIONS LLC
$47
Sobi, Inc
$46
Ipsen Biopharmaceuticals, Inc
$46
Deciphera Pharmaceuticals Inc.
$45
TAIHO ONCOLOGY, INC.
$44
GE HealthCare
$40
TESARO, Inc.
$39
Taiho Oncology, Inc.
$38
CTI BioPharma Corp.
$38
Pharmacosmos Therapeutics Inc.
$35
ADC Therapeutics America, Inc.
$32
Kyowa Kirin, Inc.
$30
SpringWorks Therapeutics, Inc.
$29
TG THERAPEUTICS, INC.
$28
ImmunoGen, Inc.
$28
KADMON PHARMACEUTICALS LLC
$26
Tempus AI, Inc
$26
Fennec Pharmaceuticals, Inc.
$25
Epizyme, Inc.,
$25
Sumitomo Pharma America, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$21
Servier Pharmaceuticals LLC
$19
Apellis Pharmaceuticals, Inc.
$19
Agios Pharmaceuticals, Inc.
$17
Partner Therapeutics, Inc.
$16
INSYS Therapeutics Inc
$15
Myovant Sciences Inc.
$15
TerSera Therapeutics LLC
$15
AVEO Pharmaceuticals, Inc.
$15
Dova Pharmaceuticals
$15
Array BioPharma Inc.
$13
ADMA BioManufacturing LLC
$4
Top 3 companies account for 19.1% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALOXI · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · COSELA · CYMBALTA · CYRAMZA · Cabometyx · Columvi · Cresemba · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ERBITUX · ERLEADA · EXKIVITY · Empaveli · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · FUJIFILM · Fabhalta · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · PROMACTA · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAXOTERE · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $37 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
62
Per 100K population
10.5
County median income
$67,384
Nearest hospital
HCA FLORIDA TRINITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kulkarni is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kulkarni experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kulkarni performed 33,150 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kulkarni receive payments from pharmaceutical companies?
Yes. Dr. Kulkarni received a total of $18,351 from 86 companies across 975 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kulkarni's costs compare to other medical oncologys in Trinity?
Dr. Kulkarni's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kulkarni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Trinity
Browse medical oncologys in Trinity ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology